ArticleFrontiers in cardiovascular medicine2022

Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors.

Lukas J Motloch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.